1 01/03/2023 28/02/2024 2024-02-28 false false false false false false false true false false true false false false false false false false No description of principal activities is disclosed 2023-03-01 Sage Accounts Production 24.0 - FRS102_2024 xbrli:pure xbrli:shares iso4217:GBP 13885050 2023-03-01 2024-02-28 13885050 2024-02-28 13885050 2023-02-28 13885050 2022-03-01 2023-02-28 13885050 2023-02-28 13885050 2022-02-28 13885050 bus:RegisteredOffice 2023-03-01 2024-02-28 13885050 bus:Director1 2023-03-01 2024-02-28 13885050 core:WithinOneYear 2024-02-28 13885050 core:WithinOneYear 2023-02-28 13885050 bus:Director1 2023-02-28 13885050 bus:Director1 2024-02-28 13885050 bus:Director1 2023-02-28 13885050 bus:Director1 2022-03-01 2023-02-28 13885050 bus:Micro-entities 2023-03-01 2024-02-28 13885050 bus:AuditExempt-NoAccountantsReport 2023-03-01 2024-02-28 13885050 bus:SmallCompaniesRegimeForAccounts 2023-03-01 2024-02-28 13885050 bus:PrivateLimitedCompanyLtd 2023-03-01 2024-02-28 13885050 bus:FullAccounts 2023-03-01 2024-02-28
Company registration number: 13885050
M&F Medics Ltd
Unaudited filleted financial statements
28 February 2024
M&F Medics Ltd
Contents
Directors and other information
Statement of financial position and notes to the financial statements
M&F Medics Ltd
Directors and other information
Directors Dr Faiza Hassan
Company number 13885050
Registered office 10 Netherfield Road
Harpenden
Hertfordshire
AL5 2AG
M&F Medics Ltd
Statement of financial position
28 February 2024
28/02/24 28/02/23
£ £
Current assets 7,940 17,917
Creditors: amounts falling due within one year ( 2,580) ( 10,413)
_______ _______
Net current assets 5,360 7,504
_______ _______
Total assets less current liabilities 5,360 7,504
Accruals and deferred income ( 250) ( 650)
_______ _______
Net assets 5,110 6,854
_______ _______
Capital and reserves 5,110 6,854
_______ _______
Notes to the financial statements
M&F Medics Ltd
Year ended 28 February 2024
1. Employee numbers
The average number of persons employed by the company during the year amounted to 1 (2023: 1 ).
2. Directors advances, credits and guarantees
During the year the directors entered into the following advances and credits with the company:
Year ended 28/02/24
Balance brought forward Advances /(credits) to the directors Balance o/standing
£ £ £
Dr Faiza Hassan ( 8,336) 5,756 ( 2,580)
_______ _______ _______
Period ended 28/02/23
Balance brought forward Advances /(credits) to the directors Balance o/standing
£ £ £
Dr Faiza Hassan - ( 8,336) ( 8,336)
_______ _______ _______
For the year ending 28 February 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Directors responsiblities:
- The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476.
- The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
The financial statements have been prepared in accordance with the micro-entity provisions and have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.
These financial statements were approved by the board of directors and authorised for issue on 26 January 2025 , and are signed on behalf of the board by:
Dr Faiza Hassan
Director
Company registration number: 13885050
The company is a private company limited by shares, registered in England & Wales.